Literature DB >> 16405912

Recombinant human PPAR-beta/delta ligand-binding domain is locked in an activated conformation by endogenous fatty acids.

Stewart A Fyffe1, Magnus S Alphey, Lori Buetow, Terry K Smith, Michael A J Ferguson, Morten D Sørensen, Fredrik Björkling, William N Hunter.   

Abstract

High-resolution crystallographic structures of recombinant human peroxisome proliferator-activated receptor ligand-binding domain (isotype beta/delta) reveal a fatty acid in the binding site. Mass spectrometry confirmed the presence of C16:0, C16:1, C18:0 and C18:1 in a ratio of approximately 3:2:1:4 with 11, Z-octadecenoic acid (cis-vaccenic acid) identified as the predominant species. These are endogenous fatty acids acquired from the bacterial expression system, and serve to lock the ligand-binding domain into the activated conformation. A requirement for crystal growth, the additive n-heptyl-beta-d-glucopyranoside, binds near the activation function helix where recognition of co-activator proteins occurs. Our observations suggest potential physiological ligands for human PPAR-beta/delta and highlight that reported binding studies must be treated with caution unless endogenous fatty acids have been removed from the sample prior to analysis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16405912     DOI: 10.1016/j.jmb.2005.12.047

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  29 in total

1.  Identification and Molecular Characterization of Peroxisome Proliferator-Activated Receptor δ as a Novel Target for Covalent Modification by 15-Deoxy-Δ12,14-prostaglandin J2.

Authors:  Aravind T Reddy; Sowmya P Lakshmi; Asoka Banno; Raju C Reddy
Journal:  ACS Chem Biol       Date:  2018-11-29       Impact factor: 5.100

2.  Ligand-activated PPARbeta efficiently represses the induction of LXR-dependent promoter activity through competition with RXR.

Authors:  Kimihiko Matsusue; Aya Miyoshi; Shigeru Yamano; Frank J Gonzalez
Journal:  Mol Cell Endocrinol       Date:  2006-08-15       Impact factor: 4.102

Review 3.  Activation of PPARδ: from computer modelling to biological effects.

Authors:  Shirin Kahremany; Ariela Livne; Arie Gruzman; Hanoch Senderowitz; Shlomo Sasson
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

Review 4.  Adipose Tissue in HIV Infection.

Authors:  John R Koethe
Journal:  Compr Physiol       Date:  2017-09-12       Impact factor: 9.090

5.  Structural basis for specific ligation of the peroxisome proliferator-activated receptor δ.

Authors:  Chyuan-Chuan Wu; Thomas J Baiga; Michael Downes; James J La Clair; Annette R Atkins; Stephane B Richard; Weiwei Fan; Theresa A Stockley-Noel; Marianne E Bowman; Joseph P Noel; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-20       Impact factor: 11.205

6.  PPARdelta is a fatty acid sensor that enhances mitochondrial oxidation in insulin-secreting cells and protects against fatty acid-induced dysfunction.

Authors:  Kim Ravnskjaer; Francesca Frigerio; Michael Boergesen; Tina Nielsen; Pierre Maechler; Susanne Mandrup
Journal:  J Lipid Res       Date:  2009-11-30       Impact factor: 5.922

7.  Pharmacophore modeling and parallel screening for PPAR ligands.

Authors:  Patrick Markt; Daniela Schuster; Johannes Kirchmair; Christian Laggner; Thierry Langer
Journal:  J Comput Aided Mol Des       Date:  2007-10-25       Impact factor: 3.686

Review 8.  Lysophospholipid interactions with protein targets.

Authors:  Abby L Parrill
Journal:  Biochim Biophys Acta       Date:  2008-05-02

9.  PPAR-delta in Vascular Pathophysiology.

Authors:  Nanping Wang
Journal:  PPAR Res       Date:  2009-01-06       Impact factor: 4.964

10.  Adaptability and selectivity of human peroxisome proliferator-activated receptor (PPAR) pan agonists revealed from crystal structures.

Authors:  Takuji Oyama; Kenji Toyota; Tsuyoshi Waku; Yuko Hirakawa; Naoko Nagasawa; Jun Ichi Kasuga; Yuichi Hashimoto; Hiroyuki Miyachi; Kosuke Morikawa
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.